Dorman (DORM) Q3 2025 Earnings Transcript

Dorman Products reported Q3 net sales of $544 million, up 7.9% year over year, with adjusted operating income rising 30% to $111 million and adjusted diluted EPS increasing 34% to $2.62. Gross margin expanded 390 basis points to 44.4% and operating margin improved to 20.5%, aided by tariff-related pricing and supplier diversification, though management expects Q4 gross margin compression as higher-cost tariff inventory flows through COGS. Full-year guidance was reaffirmed at 7%-9% sales growth and $8.60-$8.90 adjusted EPS, but share repurchases remain paused amid tariff uncertainty.

Analysis

The key incrementally bullish signal is not the headline growth, but the company’s ability to reprice faster than its cost base while protecting share in a tariff shock. That implies DORM is functioning as a quasi-inflation hedge in hard-parts repair, where demand is more resilient than consensus typically assumes; the second-order benefit is that competitors with more discretionary, more China-linked, or less engineered product mixes will see margin compression before they can fully re-source. The current quarter likely represents the high-water mark for easy tariff-driven gross margin optics, but the business model still looks structurally better post-diversification than it did 12-24 months ago.

The important risk is timing mismatch: pricing is front-loaded, but tariff-inflated inventory cost flows through later. That creates a near-term earnings quality issue in Q4 and potentially a transient multiple de-rating if investors focus on margin compression instead of normalized run-rate earnings power. Cash flow is the more credible tell over the next 1-2 quarters: if working capital stays elevated and repurchases remain paused, the market may start discounting the idea that tariff pass-through is as clean as management suggests.

The contrarian angle is that the market may be underestimating how much of DORM’s growth is share capture rather than simple pass-through. New product content in light duty and the shift toward nondiscretionary specialty parts suggest a longer-duration earnings step-up, not just a one-off tariff repricing cycle. The cleanest read-through is that management is effectively building an earnings moat via supply chain optionality; that should lower the terminal risk premium if they can show stable margins once Q4 cost headwinds clear.

Key Decisions for Investors

• Long DORM into Q4 margin-compression: use a 2-3 month horizon and expect headline gross margin pressure to create a better entry; target 8-12% upside if the market overreacts to the Q4 guide.
• Buy DORM Jan-2026 calls or call spreads on any post-earnings pullback: the setup is asymmetric if tariff pass-through proves durable and Q4 cash flow inflects back up by year-end.
• Pair trade: long DORM / short a more China-exposed auto-aftermarket or industrial supplier with lower pricing power; the trade monetizes supply-chain diversification as a relative-margin advantage over 1-2 quarters.
• Trim exposure if operating cash flow/free cash flow do not rebound by the next quarter: that would signal inventory drag is persisting longer than management implies and reduce confidence in the earnings quality story.
• If you need lower-volatility exposure, express the view through a long DORM vs short consumer-discretionary auto accessory proxy; DORM’s nondiscretionary mix should outperform if tariffs or rates keep pressuring end demand.